ERP measures may also be relevant to the distinctive mGluR5 dysregulation in FXS, since the mGluR5 antagonist MPEP reduced N1 auditory EP amplitudes in a mouse model of ASD [223]. The gene discussed is GRM5; the disease is fragile X syndrome.